AF
KYNB

Allworth Financial’s Kyntra Bio KYNB Stock Holding History

Allworth Financial’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1
Closed -$46 – 3475
2023
Q2 		$46 Hold
1
– – ﹤0.01% 3196
2023
Q1 		$318 Hold
1
– – ﹤0.01% 2926
2022
Q4 		$272 Hold
1
– – ﹤0.01% 2744
2022
Q3 		$0 Buy
+1
New +$322 ﹤0.01% 2797

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allworth Financial's KYNB Position: Q3 2023 in Review

Allworth Financial sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 1 share — an estimated $46 sold.

Allworth Financial first reported a position in KYNB in Q3 2022 and held it in 4 quarters. The position peaked at $318 in Q1 2023. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • Allworth Financial reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • Allworth Financial sold 1 Kyntra Bio share in Q3 2023, an estimated $46.
  • Allworth Financial first reported a position in Kyntra Bio in Q3 2022 and held it in 4 quarters.
  • Allworth Financial's Kyntra Bio position peaked at $318 in Q1 2023.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on Allworth Financial's 13F filing for Q3 2023, filed 31 Oct 2023.